Status:
RECRUITING
FAZA PET/MRI in CLI Patients Pre and Post Revascularization
Lead Sponsor:
University Health Network, Toronto
Conditions:
Critical Limb Ischemia
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
Peripheral artery disease is a worldwide problem, leading to high mortality and mobility. Critical limb ischemia (CLI) is associated with high risk of amputation with the subsequent decreased in life...
Eligibility Criteria
Inclusion
- Age \>= 18 years;
- Patients with clinical evidence of critical limb ischemia that are candidates for revascularization treatment;
- A negative urine or serum pregnancy test in women of child-bearing age;
- Ability to provide written informed consent to participate in the study.
Exclusion
- Contraindication for MR as per current institutional guidelines;
- Inability to lie supine for at least 30 minutes;
- Pregnant or breastfeeding;
- Unable or unwilling to provide informed consent;
- Impending amputation within 6 weeks of presentation;
- Previous metallic hardware in the lower limbs;
- Unable to have ethanol.
Key Trial Info
Start Date :
August 31 2019
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
December 1 2025
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04054609
Start Date
August 31 2019
End Date
December 1 2025
Last Update
March 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
University Health Network
Toronto, Ontario, Canada, M5G 2N2